Overview

Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects

Status:
COMPLETED
Trial end date:
2024-07-03
Target enrollment:
Participant gender:
Summary
The drug-drug interaction study has been designed to investigate the effect of Fluvoxamine, Itraconazole and Paroxetine on the pharmacokinetics of ASN51
Phase:
PHASE1
Details
Lead Sponsor:
Asceneuron S.A.
Treatments:
Fluvoxamine
Itraconazole
Paroxetine